Kortchak S - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Human cathelicidin peptide LL-37 as a therapeutic antiviral targeting Venezuelan equine encephalitis virus infections.

Ahmed A, Siman-Tov G, Keck F, Kortchak S, Bakovic A, Risner K, Lu TK, Bhalla N, de la Fuente-Nunez C, Narayanan A. Ahmed A, et al. Among authors: kortchak s. Antiviral Res. 2019 Apr;164:61-69. doi: 10.1016/j.antiviral.2019.02.002. Epub 2019 Feb 8. Antiviral Res. 2019. PMID: 30738837

Direct and indirect pro-inflammatory cytokine response resulting from TC-83 infection of glial cells.

Keck F, Kortchak S, Bakovic A, Roberts B, Agrawal N, Narayanan A. Keck F, et al. Among authors: kortchak s. Virulence. 2018;9(1):1403-1421. doi: 10.1080/21505594.2018.1509668. Virulence. 2018. PMID: 30101649 Free PMC article.

Efficacy of FDA-Approved Anti-Inflammatory Drugs Against Venezuelan Equine Encephalitis Virus Infection.

Risner K, Ahmed A, Bakovic A, Kortchak S, Bhalla N, Narayanan A. Risner K, et al. Among authors: kortchak s. Viruses. 2019 Dec 12;11(12):1151. doi: 10.3390/v11121151. Viruses. 2019. PMID: 31842327 Free PMC article.

Venezuelan Equine Encephalitis Virus nsP3 Phosphorylation Can Be Mediated by IKKβ Kinase Activity and Abrogation of Phosphorylation Inhibits Negative-Strand Synthesis.

Bakovic A, Bhalla N, Kortchak S, Sun C, Zhou W, Ahmed A, Risner K, Klimstra WB, Narayanan A. Bakovic A, et al. Among authors: kortchak s. Viruses. 2020 Sep 13;12(9):1021. doi: 10.3390/v12091021. Viruses. 2020. PMID: 32933112 Free PMC article.

Synthetic Host Defense Peptides Inhibit Venezuelan Equine Encephalitis Virus Replication and the Associated Inflammatory Response.

Ahmed A, Bakovic A, Risner K, Kortchak S, Der Torossian Torres M, de la Fuente-Nunez C, Lu T, Bhalla N, Narayanan A. Ahmed A, et al. Among authors: kortchak s. Sci Rep. 2020 Dec 8;10(1):21491. doi: 10.1038/s41598-020-77990-3. Sci Rep. 2020. PMID: 33293592 Free PMC article.

CT109-SN-38, a Novel Antibody-drug Conjugate with Dual Specificity for CEACAM5 and 6, Elicits Potent Killing of Pancreatic Cancer Cells.

Cardenas KCA, Enos CW, Spear MR, Austin DE, Almofeez R, Kortchak S, Pincus L, Guo HB, Dolezal S, Pierce JM, Furth E, Gineste C, Kwon Y, Gelber C. Cardenas KCA, et al. Among authors: kortchak s. Curr Cancer Drug Targets. 2024;24(7):720-732. doi: 10.2174/0115680096260614231115192343. Curr Cancer Drug Targets. 2024. PMID: 38178674

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6 results

Search Page

Filters